The study showed that Polycap lowered blood pressure and cholesterol without many side effects. Doctor Yusuf said the single pill, taken once a day, could reduce the average person's risk of heart ...

The primary objective of TIPS is to determine whether the effects of the Polycap are noninferior to those of its equivalent components. Specifically, we aim to test whether the Polycap reduces ...

The Indian Polycap Study (TIPS). Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial ...

The Indian Polycap Study is sponsored by Cadila Pharmaceuticals India Ltd. The study is registered with www.clinicaltrials.org (NCT00443794) and the Clinical Trials Register of India (CTRI/2008 ...

Cadilla's 'magic bullet' polycap clears first big test. 01 April 2009. A single pill that contains five life-saving drugs to guard against heart disease and strokes has come closer to reality ...

Polycap LLC, a Toronto-based manufacturer of specialty caps and closures for a number of vertical markets, will invest $7.7 million to establish its first U.S. manufacturing facility in a 76,000- ...

Cardiovascular diseases, predominantly heart disease and stroke account for around 30% of all deaths around the world.

Polymathes Capital has sponsored a recapitalization of Precision Aerospace Components, a maker of products and components for the aerospace and military applications. No financial terms were ...

New Delhi: Ahmedabad-based Cadila Pharmaceuticals is looking for global tie-ups to market its new patented product - Polycap - a combination of five medicines that prevents heart attack. “We ...